Heparin-Akrihin 1000 gel for planks. approx. 1000IU / g tube 50g
Dosage:
1000IU / g x 30g
1000IU / g x 50g
Scope of the drug
Heart, vessels, blood
Release form
Gel
Manufacturer country
Russia
Package quantity, pcs
one
Scope of application
Cardiology
,
Angiology
,
Phlebology
Release form
gel for external use
pharmachologic effect
Heparin-Akrigel 1000 has a moderate anti-inflammatory and anti-edema effect, prevents the formation of blood clots.
Indications
Thrombophlebitis of superficial veins.
Localized infiltrates and soft tissue edema.
Tendon and joint injuries.
Contusions of soft tissues and joints.
Contraindications
Hypersensitivity to any of the components of Heparin-Akrigel 1000.
Necrotic ulcerative changes in the skin at the sites of the intended application of the gel.
Traumatic violation of the integrity of the skin.
Reduced blood clotting.
Thrombocytopenia.
special instructions
It is not recommended to use it for bleeding, as well as on open wounds, mucous membranes and in the presence of local purulent processes.
Use with extreme caution in case of increased vascular permeability.
The use of the gel is not recommended for deep venous thrombosis.
Structure
1 g of gel contains:
active substance: heparin 1000 ME,
excipients: methyl parahydroxybenzoate, carbomer 940 or 980, trometamol, rectified ethyl alcohol, lavender oil, neroli oil, purified water
Method of administration and dosage
Outwardly.
Gel Heparin-Akrigel 1000 is applied in a thin layer to the affected area at the rate of 3-5 cm of gel on a skin with a diameter of 3-5 cm and gently rubbed into the skin.
Apply 1-3 times a day every day until the inflammation disappears, on average from 3 to 7 days.
Side effects
Allergic skin reactions.
Hyperemia of the skin.
Drug interactions
It is not recommended to mix with other agents for external use, do not prescribe locally simultaneously with non-steroidal anti-inflammatory drugs, tetracyclines, antihistamines.
Storage conditions
In a dark place at a temperature not exceeding 25 ° C.
Shelf life
2 years.
Active substance
Heparin sodium
Name ENG
HEPARIN-AKRIKHIN 1000
Clinical and pharmacological group
Drug with antithrombotic action for external use
ATX code
Heparin
Dosage
1000IU / g x 50g
Structure
1 g of gel contains: active substance: heparin 1000 ME, auxiliary substances: methyl parahydroxybenzoate, carbomer 940 or 980, trometamol, rectified ethyl alcohol, lavender oil, neroli oil, purified water
Indications
Thrombophlebitis of superficial veins. Localized infiltrates and swelling of soft tissues. Injuries to tendons and joints. Injuries of soft tissues and joints.
Storage conditions and periods
At a temperature of 15-25 degrees.
Expiration date: 2 years
Contraindications
ulcerative necrotic changes in the skin at the sites of the intended application of the drug
traumatic violation of the integrity of the skin
thrombocytopenia
decreased blood clotting
known hypersensitivity to any component of the drug
INN / Active ingredient
Heparin sodium
Specifications
Scope of the drug
Heart, vessels, blood
Release form
Gel
Manufacturer country
Russia
Package quantity, pcs
one
Scope of application
Cardiology
,
Angiology
,
Phlebology
Way of introduction
Locally
,
Outwardly
Vacation conditions
Without recipe
Brand name
Akrikhin
The amount of the dosage form in the primary package
50 g
Primary packaging type
Tuba
Type of consumer packaging
Pack of cardboard
Anatomical and therapeutic characteristics
C05BA03 Heparin sodium
Dosage form
Gel for external use
The target audience
Adult
Expiration date in days
730
Dosage (volume) of the substance in the preparation
1 g gel: heparin 1000 IU
Package weight, g
75
Category
:
Improving blood circulation
,
Angioprotectors and microcirculation correctors
,
Lipid-lowering drugs
,
Hematopoietic stimulants
Mode of application
:
Outwardly.
Gel Heparin-Akrigel 1000 is applied in a thin layer to the affected area at the rate of 3-5 cm of gel on a skin with a diameter of 3-5 cm and gently rubbed into the skin.
Apply 1-3 times a day every day until the inflammation disappears, on average from 3 to 7 days. < br>
Pharmaco-therapeutic group
:
Direct-acting anticoagulant for topical use